126 related articles for article (PubMed ID: 12014748)
41. GOG-99: ending the controversy regarding pelvic radiotherapy for endometrial carcinoma?
Creutzberg CL
Gynecol Oncol; 2004 Mar; 92(3):740-3. PubMed ID: 14984935
[No Abstract] [Full Text] [Related]
42. Clinical and anatomical guidelines in pelvic cancer contouring for radiotherapy treatment planning.
Portaluri M; Bambace S; Perez C; Giuliano G; Angone G; Scialpi M; Pili G; Didonna V; Alloro E
Cancer Radiother; 2004 Aug; 8(4):222-9. PubMed ID: 15450515
[TBL] [Abstract][Full Text] [Related]
43. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
44. When and how should adjuvant radiation be used in early endometrial cancer?
Alektiar KM
Semin Radiat Oncol; 2006 Jul; 16(3):158-63. PubMed ID: 16814156
[TBL] [Abstract][Full Text] [Related]
45. Response to the letter of Dr. Cohen.
Sigmon WR
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):692-3. PubMed ID: 7852147
[No Abstract] [Full Text] [Related]
46. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.
Ahamad A; D'Souza W; Salehpour M; Iyer R; Tucker SL; Jhingran A; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1117-24. PubMed ID: 15990017
[TBL] [Abstract][Full Text] [Related]
47. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T;
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):168-73. PubMed ID: 15093913
[TBL] [Abstract][Full Text] [Related]
48. Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach.
Lupe K; Kwon J; D'Souza D; Gawlik C; Stitt L; Whiston F; Nascu P; Wong E; Carey MS
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):110-6. PubMed ID: 17084542
[TBL] [Abstract][Full Text] [Related]
49. Rectal angiosarcoma after adjuvant chemoradiotherapy for adenocarcinoma of the rectum.
Tardío JC; Nájera L; Alemany I; Martín T; Castaño A; Pérez-Regadera JF
J Clin Oncol; 2009 Sep; 27(27):e116-7. PubMed ID: 19667271
[No Abstract] [Full Text] [Related]
50. [Intensity modulated radiation therapy for patients with gynecological malignancies after hysterectomy and chemotherapy/radiotherapy].
Chen ZY; Ma YB; Sheng XG; Zhang XL; Xue L; Song QQ; Liu NF; Miao HQ
Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):305-8. PubMed ID: 17760262
[TBL] [Abstract][Full Text] [Related]
51. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
[TBL] [Abstract][Full Text] [Related]
52. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
[TBL] [Abstract][Full Text] [Related]
53. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies.
Kasibhatla M; Clough RW; Montana GS; Oleson JR; Light K; Steffey BA; Jones EL
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):398-403. PubMed ID: 16542793
[TBL] [Abstract][Full Text] [Related]
54. [Colonic neoplasms following radiotherapy of the female genital organs].
Yasargil EC; Bregulla KG
Helv Chir Acta; 1967 Oct; 34(5):399-405. PubMed ID: 4964312
[No Abstract] [Full Text] [Related]
55. Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group.
Sutton G; Axelrod JH; Bundy BN; Roy T; Homesley H; Lee RB; Gehrig PA; Zaino R
Gynecol Oncol; 2006 Feb; 100(2):349-54. PubMed ID: 16213007
[TBL] [Abstract][Full Text] [Related]
56. Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma.
Akahira J; Tokunaga H; Toyoshima M; Takano T; Nagase S; Yoshinaga K; Tase T; Wada Y; Ito K; Niikura H; Yamada H; Sato A; Sasano H; Yaegashi N
Oncology; 2006; 71(5-6):333-40. PubMed ID: 17690557
[TBL] [Abstract][Full Text] [Related]
57. [Effect of pelvic lymphadenectomy on prognosis of endometrial carcinoma].
Wen HW; Zhang LD
Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):152-5. PubMed ID: 15130370
[TBL] [Abstract][Full Text] [Related]
58. The role of radiation therapy in locally advanced endometrial cancer.
Anderson PR
Semin Radiat Oncol; 2006 Jul; 16(3):152-7. PubMed ID: 16814155
[TBL] [Abstract][Full Text] [Related]
59. Second neoplasms in survivors of endometrial cancer: impact of radiation therapy.
Kumar S; Shah JP; Bryant CS; Awonuga AO; Imudia AN; Ruterbusch JJ; Cote ML; Ali-Fehmi R; Morris RT; Malone JM
Gynecol Oncol; 2009 May; 113(2):233-9. PubMed ID: 19249081
[TBL] [Abstract][Full Text] [Related]
60. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
